Erratum
Jong Yoon Bahk, Steven K. Huang(University of California, Berkeley), Miguel Srougi(D’Or Institute for Research and Education), Eva Koch, Hitendra Patel(UC San Diego Health System), Axel S. Merseburger(Universitäres Kinderwunschzentrum Lübeck), Carsten Kempkensteffen(Charité - Universitätsmedizin Berlin), Alessandro Sciarra(Policlinico Umberto I), Valeria Panebianco(Sapienza University of Rome), Alfarone Andrea, Burcu Esen Akkaş, Indra Sekhar Sen(Woods Hole Oceanographic Institution), Ulderico Parente, S. Mičić(Polyclinic General Hospital), Siân Allen, Kurt Miller, Perikles Simon(Johannes Gutenberg University Mainz), M.T. Kitapci, Hui‐Ju Tsai(National Health Research Institutes), Frank Christoph(Charité - Universitätsmedizin Berlin), Chi‐Jung Chung(China Medical University), Martin Schostak(Aturo), Miroslav Stojadinović, Stephan Kruck(University Children's Hospital Tübingen), Stefan Hinz(Karlsruhe Institute of Technology), Roberto Passariello(Ospedale di Cattinara), Magnus Von Heland(Policlinico Umberto I), Oliver W. Hakenberg(University of Rostock), Arnulf Stenzl(University of Tübingen), Bong Chul Chung, Timo Joensuu(University of Helsinki), Jeong Hee Lee(Suzhou Electronic Products Inspection), Ursula Kuehs, D. Milovanović, Myeong Ok Kim(Gyeongsang National University), Markus A. Kuczyk(Medizinische Hochschule Hannover), Seung Ki Min, Cenk Acar, F. Di Silverio(Sapienza University of Rome), Jason John, Joerg Hennenlotter, Mark Schrader(Arbeitsgemeinschaft Urologische Onkologie), Steffen Weikert(St. Hedwig-Krankenhaus), Moon Seok Park, Tim O’Brien, İlker Akyol, Mo-Hsiung Yang, Matthew J. Perry, Sinan Sözen(Gazi University), Hae‐Young Lee(Seoul National University Hospital)
Cited by 0
Related Papers
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|846
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676